Clopidogrel Bisulphate 75 mg + Aspirin 150 mg is a dual antiplatelet therapy (DAPT) formulation designed to prevent blood clot formation and reduce the risk of serious cardiovascular events. This combination works by inhibiting platelet aggregation through two different mechanisms, providing enhanced protection against clot-related complications. Clopidogrel blocks ADP-mediated platelet activation, while Aspirin inhibits thromboxane A2 formation. Together, they significantly lower the risk of heart attack, stroke, and peripheral arterial thrombosis. This combination is commonly prescribed after: Acute Coronary Syndrome (ACS) Myocardial Infarction (Heart Attack) Ischemic Stroke Coronary stent placement Angina It is widely recommended for long-term cardiovascular protection under medical supervision.
